Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anorectal malignant melanoma

P Luna-Perez1, D F Rodriguez, J G Macouzet

  • 1Surgical Oncology Department, Centro Medico Nacional Siglo XXI, Instituto Mexicano del Seguro Social, Mexico DF.

Surgical Oncology
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Morbidity and mortality following abdominoperineal resection for low rectal adenocarcinoma.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·2002
Same author

Preoperative chemoradiation therapy and anal sphincter preservation with locally advanced rectal adenocarcinoma.

World journal of surgery·2001
Same author

[Cystic lymphangioma of the mesentery. Clinical, radiological, and morphological analysis].

Revista de gastroenterologia de Mexico·2001
Same author

Breast carcinoma presents a decade earlier in Mexican women than in women in the United States or European countries.

Cancer·2001
Same author

Specific c-K-ras gene mutations as a tumor-response marker in locally advanced rectal cancer treated with preoperative chemoradiotherapy.

Annals of surgical oncology·2000
Same author

The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion·1999
Same journal

Comparative safety of postoperative HIPEC with recombinant mutant TNF-α versus paclitaxel for gastric cancer peritoneal metastasis: a randomized controlled trial.

Surgical oncology·2026
Same journal

Early postoperative hospital exposome stress, multisystem recovery trajectories, and long-term oncologic outcomes after curative colorectal cancer surgery.

Surgical oncology·2026
Same journal

Prognostic significance of age in adult primary intestinal diffuse large B-cell lymphoma: Insights from the SEER database.

Surgical oncology·2026
Same journal

Total neoadjuvant therapy versus standard neoadjuvant chemoradiotherapy for locally advanced rectal cancer: A systematic review and meta-analysis of long-term outcomes.

Surgical oncology·2026
Same journal

Associations of latent profiles of resilience and fear of progression with discharge symptoms and postoperative frailty among patients undergoing lung resection: A longitudinal study.

Surgical oncology·2026
Same journal

Plastic surgeon or surgical oncologist: Impact of surgical training background on outcomes in microsurgical head and neck reconstruction.

Surgical oncology·2026
See all related articles

Surgical treatment for anorectal malignant melanoma has a high recurrence rate, primarily at distant sites. Abdominoperineal resection (APR) effectiveness for larger tumors remains uncertain.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background:

  • Anorectal malignant melanoma presents significant challenges in determining optimal surgical management.
  • Existing surgical therapies lack a universally agreed-upon standard of care.

Purpose of the Study:

  • To evaluate the recurrence patterns and survival outcomes of patients treated for anorectal malignant melanoma.
  • To assess the effectiveness of different surgical interventions based on disease stage.

Main Methods:

  • Retrospective analysis of 15 patients diagnosed with anorectal malignant melanoma between 1980 and 1996.
  • Evaluation of treatment modalities including abdominoperineal resection (APR), local excision, transverse colostomy, and radiotherapy.
  • Analysis of recurrence patterns (local, inguinal, distant) and survival rates.

Related Experiment Videos

Main Results:

  • Patients with Stage I disease treated with APR or local excision experienced local recurrence (n=6) and distant metastasis (n=6).
  • Patients with Stage II and III disease treated with transverse colostomy, radiotherapy, or interferon alpha-2b all developed progressive distant disease.
  • Median survival was 12 months for Stage I versus 5 months for Stages II/III (P=0.10); overall 5-year survival was 0%.

Conclusions:

  • Distant recurrence is the predominant pattern in anorectal malignant melanoma.
  • The efficacy of abdominoperineal resection (APR) for local tumor control in melanomas exceeding 4 cm or 5 mm thickness requires further investigation.